Kathy LaPorte
Director/Board Member chez PRECIPIO, INC.
Fortune : 92 194 $ au 31/03/2024
Profil
Kathy D.
LaPorte was the founder of New Leaf Venture Partners LLC, which was founded in 2005.
She held the title of Partner at the firm.
Ms. LaPorte is also the founder of HealthTech Capital Co. Ms. LaPorte's current job(s) include being a Director at Aesthetic Sciences Corp., Precipio Diagnostics LLC, Bolt Biotherapeutics, Inc., Precipio, Inc., Elysium Therapeutics, Inc., 89bio, Inc., Q32 Bio, Inc. (Massachusetts), D2G Oncology, Inc., and CERo Therapeutics Holdings, Inc. She is also a Director at Q32 Bio, Inc.Ms. LaPorte's former job(s) include being the Chief Executive Officer at Nodality, Inc. from 2015 to 2016.
She was also a Director at Cytyc Prenatal Products Corp., Onyx Pharmaceuticals, Inc., ISTA Pharmaceuticals, Inc., VNUS Medical Technologies, Inc., Transcept Pharmaceuticals, Inc. (Old), eHealth, Inc., Affymax, Inc., Cellgate, Inc., Prometheus Laboratories, Inc., eHealthInsurance Services, Inc., California Institute for Regenerative Medicine, Pearl Therapeutics, Inc., Transcept Pharma, Inc., Phoenix Biotech Acquisition Corp., and First Boston Corp.
She was a General Partner at Sprout Group from 1993 to 2004 and a Principal at Asset Management Co. from 1987 to 1992.
She was also a Partner at New Leaf Venture Partners LLC from 2005 to 2011 and a General Partner at Credit Suisse Securities (USA) LLC in 2005.
Additionally, she served as the President of the Western Association of Venture Capitalists.
Ms. LaPorte's education includes an undergraduate degree from Yale University in 1983 and an MBA from Stanford Graduate School of Business in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PRECIPIO, INC.
0,71% | 15/04/2024 | 10 071 ( 0,71% ) | 67 476 $ | 31/03/2024 |
0,04% | 05/04/2024 | 5 828 ( 0,04% ) | 17 892 $ | 31/03/2024 |
0,00% | 25/03/2024 | 302 ( 0,00% ) | 5 146 $ | 31/03/2024 |
| 12/06/2023 | 1 200 ( 0,00% ) | 1 680 $ | 31/03/2024 | |
89BIO INC
-.--% | 01/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Kathy LaPorte
| Sociétés | Poste | Début |
|---|---|---|
| PRECIPIO, INC. | Director/Board Member | 09/08/2018 |
| BOLT BIOTHERAPEUTICS, INC. | Director/Board Member | 01/12/2020 |
| 89BIO, INC. | Director/Board Member | 01/11/2021 |
Elysium Therapeutics, Inc.
 Elysium Therapeutics, Inc. BiotechnologyHealth Technology Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH. | Director/Board Member | 01/08/2016 |
D2G Oncology, Inc.
 D2G Oncology, Inc. Pharmaceuticals: MajorHealth Technology D2G Oncology, Inc. develops relating drugs to genotypes to transform precision cancer therapeutics. The company was founded by Ian Winters and Jonathan MacQuitty in 2018 and is headquartered in Mountain View, CA. | Director/Board Member | 01/01/2020 |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Director/Board Member | 03/08/2021 |
Precipio Diagnostics LLC
 Precipio Diagnostics LLC Medical/Nursing ServicesHealth Services Precipio Diagnostics LLC operates as a cancer diagnostics reference laboratory. It offers its customers community oncologists and hospitals access to academic institutions and has combined academic-level excellence with the sales and marketing expertise, the proper operational processes and the necessary service level standards required to deliver proper support. The company was founded by Ilan Danieli in 2011 and is headquartered in New Haven, CT. | Director/Board Member | - |
Aesthetic Sciences Corp.
 Aesthetic Sciences Corp. Pharmaceuticals: MajorHealth Technology Aesthetic Sciences Corp. provides aesthetic medicine and incontinence products. It develops dermal fillers based on polymer technologies for use in the aesthetic market. The company was founded by Edward Schmitt & Gary Petersmeyer in December 2004 and is headquartered in San Francisco, CA. | Director/Board Member | - |
Anciens postes connus de Kathy LaPorte
| Sociétés | Poste | Fin |
|---|---|---|
| California Institute for Regenerative Medicine | Director/Board Member | 01/09/2017 |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Kathy LaPorte
| Yale University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| EHEALTH, INC. | Finance |
| AFFYMAX, INC. | Health Technology |
| BOLT BIOTHERAPEUTICS, INC. | Health Technology |
| PRECIPIO, INC. | Health Services |
| 89BIO, INC. | Health Technology |
| Entreprise privées | 25 |
|---|---|
| First Boston Corp. | Finance |
Cytyc Prenatal Products Corp.
 Cytyc Prenatal Products Corp. Medical SpecialtiesHealth Technology Cytyc Prenatal Products Corp. provides products for the diagnosis of pregnancy related and female reproductive disorders. The company also designs, develops, and manufactures women health care products. It was founded in 1985 and is headquartered in Sunnyvale, CA | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
ISTA Pharmaceuticals, Inc.
 ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
VNUS Medical Technologies, Inc.
 VNUS Medical Technologies, Inc. Medical SpecialtiesHealth Technology VNUS Medical Technologies, Inc. provides medical devices and procedures for the minimally invasive treatment of venous reflux disease, an underlying cause of varicose veins. Venous reflux disease results in symptoms such as leg pain, swelling, fatigue, skin ulcers, and painful varicose veins. The company was founded on January 31, 1995 and is headquartered in San Jose, CA. | Health Technology |
Transcept Pharmaceuticals, Inc. (Old)
 Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA. | Health Technology |
Aesthetic Sciences Corp.
Aesthetic Sciences Corp. Pharmaceuticals: MajorHealth Technology Aesthetic Sciences Corp. provides aesthetic medicine and incontinence products. It develops dermal fillers based on polymer technologies for use in the aesthetic market. The company was founded by Edward Schmitt & Gary Petersmeyer in December 2004 and is headquartered in San Francisco, CA. | Health Technology |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Health Technology |
Precipio Diagnostics LLC
Precipio Diagnostics LLC Medical/Nursing ServicesHealth Services Precipio Diagnostics LLC operates as a cancer diagnostics reference laboratory. It offers its customers community oncologists and hospitals access to academic institutions and has combined academic-level excellence with the sales and marketing expertise, the proper operational processes and the necessary service level standards required to deliver proper support. The company was founded by Ilan Danieli in 2011 and is headquartered in New Haven, CT. | Health Services |
Sprout Group
 Sprout Group Investment ManagersFinance Sprout Group (Sprout) is venture capital subsidiary of Credit Suisse Private Equity LLC founded in 1969. The firm headquartered in New York. | Finance |
Cellgate, Inc.
 Cellgate, Inc. Pharmaceuticals: MajorHealth Technology Progen Pharmaceuticals, Inc. develops biopharmaceuticals products. It is engaged in developing improved drug delivery based on their transporter molecules. The company is headquartered in Redwood City, CA. | Health Technology |
Asset Management Co.
 Asset Management Co. Investment ManagersFinance Asset Management Co. is a venture capital firm. The company was founded in 1965 and is headquartered in East Palo Alto, CA. | Finance |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
eHealthInsurance Services, Inc.
 eHealthInsurance Services, Inc. Life/Health InsuranceFinance eHealthInsurance Serivces, Inc. provides online health insurance plan services. It provides buying and using health insurance information through toll free number, online chat, email, fax, customer care team. The firm’s customers include individuals, families and small businesses. The company was founded in 1997 and is headquartered in Mountain View, CA. | Finance |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Finance |
Credit Suisse Securities (USA) LLC
 Credit Suisse Securities (USA) LLC Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC provides a variety of capital raising, market making, advisory and brokerage services for governments, financial institutions, high-net-worth individuals, and corporate clients and affiliates. It is also a primary dealer in U.S. government securities and an underwriter, placement agent, and dealer for money market instruments, commercial paper, mortgage and other assetbacked securities, as well as a range of debt, equity and other convertible securities of corporations and other issuers. The company was founded on January 3, 2003 and is headquartered in New York, NY. | Finance |
| California Institute for Regenerative Medicine | Government |
| Western Association of Venture Capitalists | |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Health Technology |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Health Technology |
HealthTech Capital Co.
 HealthTech Capital Co. Financial ConglomeratesFinance HealthTech Capital Co. invests in the healthcare sectors. It invests in capital efficient companies that use new scalable business model to improve the healthcare delivery from the hospital to the home. The company was founded by Anne DeGheest in 2010 and is headquartered in Los Altos Hills, CA. | Finance |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH. | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Health Technology |
D2G Oncology, Inc.
D2G Oncology, Inc. Pharmaceuticals: MajorHealth Technology D2G Oncology, Inc. develops relating drugs to genotypes to transform precision cancer therapeutics. The company was founded by Ian Winters and Jonathan MacQuitty in 2018 and is headquartered in Mountain View, CA. | Health Technology |
Phoenix Biotech Acquisition Corp.
 Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Phoenix Biotech Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on June 8, 2021 and is headquartered in Oakland, CA. | Finance |
